To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer’s Disease

by | Feb 25, 2026 | Clinical Trials | 0 comments

​ Conditions: Agitation in Dementia

Interventions: Drug: Dronabinol Oral Solution; Other: Placebo Control

Sponsors: Benuvia Therapeutics Inc.; Mandara

Not yet recruiting Conditions: Agitation in Dementia
Interventions: Drug: Dronabinol Oral Solution; Other: Placebo Control
Sponsors: Benuvia Therapeutics Inc.; Mandara
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *